Malignant Ascites
📧 Sign up to get email alerts when something new happens for Malignant Ascites.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: At-Home Paracentesis for Women With Cancer-Related Malignant Ascites (Paracentesis) [NA]
This clinical trial update describes at-home paracentesis for women with cancer-related malignant ascites, and the study is currently not ye…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing intraperitoneal liposomal irinotecan as monotherapy or in combination with recombinant mutant human tumor…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Clinical Study of GK02 in Malignant Ascites [EARLY_Phase 1]
An early-phase clinical trial investigates GK02 for malignant ascites caused by advanced solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing intraperitoneal immune checkpoint inhibitors with zoledronic acid for gastric cancer with malignant as…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: QOL and Sarcopenia in Patients With Ascites
A clinical trial is ongoing to assess quality of life and sarcopenia in patients with hepatic and malignant ascites; recruitment is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions [Phase 2]
A Phase 2 trial comparing bevacizumab plus cisplatin against cisplatin alone for malignant serous effusions is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody [Phase 3]
A Phase 3 clinical trial is evaluating M701 Bispecific Antibody for malignant ascites caused by advanced epithelial solid tumors. The study …
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: A Phase I Study of SIM0388 in Participants With Malignant Ascites. [Phase 1]
This is a Phase I clinical trial evaluating SIM0388 in participants with malignant ascites; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites [Phase 1, Phase 2]
A Phase 1/2 trial evaluating SK-NK Injection in patients with advanced solid tumors and malignant ascites; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer [Phase 1]
Phase 1 trial evaluating delivery of tocilizumab via pleural and peritoneal catheters in patients with advanced metastatic cancer, including…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: International Alfapump Cohort Study
Update on the International Alfapump Cohort Study showing the trial is active but not recruiting, sponsored by Sequana Medical N.V., for liv…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites [Phase 2]
Phase 2 trial evaluating the combination of bevacizumab, serplulimab, and rmhTNF-NC for malignant ascites; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2022-08-15Clinical Trial Update: PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites [Phase 1, Phase 2]
A clinical trial exploring intraperitoneal perfusion of a PD-1 inhibitor combined with PRaG therapy for malignant ascites in Phase 1/2.
-
CLINICAL_TRIALS research · 2018-06-11Clinical Trial Update: Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis
This clinical trial update investigates quality of life in patients with malignant ascites treated with rocket indwelling pleural catheter d…
-
CLINICAL_TRIALS research · 2018-06-08Clinical Trial Update: EUS-Guided Drainage of Refractory Malignant Ascites
This is an ongoing clinical trial evaluating endoscopic ultrasound-guided drainage for refractory malignant ascites, sponsored by Hospital U…
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites [Phase 2]
Phase 2 clinical trial evaluating Apatinib for subjects with refractory malignant ascites is described. The current status of the study is u…
-
CLINICAL_TRIALS research · 2016-06-23Clinical Trial Update: The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites [NA]
This clinical trial update examines the role of intravenous albumin replacement during abdominal paracentesis in patients with cancer-relate…
-
CLINICAL_TRIALS research · 2013-05-21Clinical Trial Update: Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites [Phase 1]
Phase I trial update for intraperitoneal bevacizumab in refractory malignant ascites; no status or results details are provided.